Data / Form D filings / CANTEX PHARMACEUTICALS, INC.
CANTEX PHARMACEUTICALS, INC.: Form D filings
CANTEX PHARMACEUTICALS, INC., a pharmaceuticals company in Weston, FL, filed 4 Form D notices with the SEC between 2010 and 2014. The latest, on April 23, 2014, reports $3.3 million sold of a $3.3 million offering to 7 investors.
Find out what CANTEX PHARMACEUTICALS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1792 BELL TOWER LANE, SUITE 222, Weston, FL, 33326
- Phone
- (954) 315-3660
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1374961
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 23, 2014 | Amendment | $3,270,326 | $3,270,326 | $0 | 7 | Feb 8, 2013 | sec.gov |
| Oct 31, 2013 | Amendment | $2,270,225 | $2,270,225 | $0 | 6 | Feb 8, 2013 | sec.gov |
| Feb 19, 2013 | New notice | $2,000,000 | $700,000 | $1,300,000 | 5 | Feb 8, 2013 | sec.gov |
| Aug 4, 2010 | New notice | $5,000,220 | $4,394,613 | $605,607 | 4 | Aug 3, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Claude G. Bertrand | Executive Officer | |
| Stephen G. Marcus | Executive Officer, Director | |
| Neil A. Flanzraich | Executive Officer, Director | |
| Christopher A. Kroeger | Director | |
| Todd C. Brady | Director |
Other pharmaceuticals companies in Florida that filed recently
- GOA Therapeutics Corp $300,000 · Nov 5, 2026
- DalCor Pharmaceuticals US, LLC $7 million · Aug 28, 2026
Every Form D from the week of Apr 21, 2014 · All recent filings in Florida · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what CANTEX PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.